Segment Information (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Segment

	Three months ended March 31,
Sale of Product	2019		2018
Radiochemical Products	$	463,232	$	583,541
Cobalt Products		376,089		327,778
Nuclear Medicine Standards		1,100,922		1,002,113
Radiological Services		587,609		887,594
Fluorine Products		—		—
Total Segments		2,527,852		2,801,026
Corporate revenue		—		—
Total Consolidated	$	2,527,852	$	2,801,026

	Three months ended March 31,
Depreciation and Amortization	2019		2018
Radiochemical Products	$	8,817	$	5,014
Cobalt Products		1,080		4,043
Nuclear Medicine Standards		15,619		17,938
Radiological Services		8,636		12,039
Fluorine Products		26,095		26,095
Total Segments		60,248		65,130
Corporate depreciation and amortization		4,737		4,844
Total Consolidated	$	64,985	$	69,974

	Three months ended March 31,
Segment Income (Loss)	2019			2018
Radiochemical Products	$	96,006		$	40,520
Cobalt Products		192,870			184,792
Nuclear Medicine Standards		216,822			223,942
Radiological Services		311,279			402,012
Fluorine Products		(37,495	)		(31,299	)
Total Segments		779,481			819,966
Corporate loss		(831,439	)		(785,562	)
Net Income (Loss)	$	(51,958	)	$	34,404

	Three months ended March 31,
Expenditures for Segment Assets	2019		2018
Radiochemical Products	$	—	$	—
Cobalt Products		3,494		—
Nuclear Medicine Standards		—		18,148
Radiological Services		—		—
Fluorine Products		1,590		1,560
Total Segments		5,084		19,708
Corporate purchases		—		—
Total Consolidated	$	5,084	$	19,708

	March 31,		December 31,
Segment Assets	2019		2018
Radiochemical Products	$	287,605	$	344,994
Cobalt Products		3,095,941		2,611,939
Nuclear Medicine Standards		2,200,139		2,113,960
Radiological Services		535,829		281,077
Fluorine Products		5,563,206		5,590,053
Total Segments		11,682,720		10,942,023
Corporate assets		2,416,416		2,048,053
Total Consolidated	$	14,099,136	$	12,990,076